サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1215037

世界のうっ血性心不全治療装置市場：考察と予測 (2029年まで)

Global Congestive Heart Failure (CHF) Treatment Devices Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 109 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.85円
世界のうっ血性心不全治療装置市場：考察と予測 (2029年まで)
出版日: 2023年02月13日
発行: QYResearch
ページ情報: 英文 109 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、うっ血性心不全治療装置 (Congestive Heart Failure (CHF) Treatment Devices) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • うっ血性心不全治療装置の製品概要
  • 市場：タイプ別
    • 世界のうっ血性心不全治療装置の市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • Cardiac Resynchronization Therapy (CRT)
    • Implantable Cardioverter Defibrillators (ICDs)
  • 市場：用途別
    • 世界のうっ血性心不全治療装置の市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • Left Ventricular Assist Device (LVAD)
    • Right Ventricular Assist Device (RVAD)
    • Biventricular Assist Device (BIVAD)
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界のうっ血性心不全治療装置売上予測・予想 2018-2029
  • 世界のうっ血性心不全治療装置の収益：地域別
    • 世界のうっ血性心不全治療装置の収益：地域別: 2018 VS 2022 VS 2029
    • 世界のうっ血性心不全治療装置の収益：地域別 (2018-2023)
    • 世界のうっ血性心不全治療装置の収益：地域別 (2024-2029)
    • 世界のうっ血性心不全治療装置の収益市場シェア 地域別 (2018-2029)
  • 世界のうっ血性心不全治療装置売上予測・予想 2018-2029
  • 世界のうっ血性心不全治療装置の販売：地域別
    • 世界のうっ血性心不全治療装置の販売：地域別: 2018 VS 2022 VS 2029
    • 世界のうっ血性心不全治療装置の販売：地域別 (2018-2023)
    • 世界のうっ血性心不全治療装置の販売：地域別 (2024-2029)
    • 世界のうっ血性心不全治療装置の販売市場シェア 地域別 (2018-2029)
  • US & カナダ
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

  • 世界のうっ血性心不全治療装置の販売：企業別
    • 世界のうっ血性心不全治療装置の販売：企業別 (2018-2023)
    • 世界のうっ血性心不全治療装置の販売市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： うっ血性心不全治療装置2022
  • 世界のうっ血性心不全治療装置の収益：企業別
    • 世界のうっ血性心不全治療装置の収益：企業別 (2018-2023)
    • 世界のうっ血性心不全治療装置の収益市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： うっ血性心不全治療装置の収益 2022
  • 世界の主要企業 うっ血性心不全治療装置, 業界ランキング, 2021 VS 2022 VS 2023
  • 世界のうっ血性心不全治療装置の販売価格：企業別
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界のうっ血性心不全治療装置の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー うっ血性心不全治療装置, 製造拠点分布と本社
  • 世界の主要メーカー うっ血性心不全治療装置, 提供製品と用途
  • 世界の主要メーカー うっ血性心不全治療装置, 業界参入時期
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界のうっ血性心不全治療装置の販売：タイプ別
    • 世界のうっ血性心不全治療装置の販売実績：タイプ別 (2018-2023)
    • 世界のうっ血性心不全治療装置の販売予測：タイプ別 (2024-2029)
    • 世界のうっ血性心不全治療装置の販売市場シェア：タイプ別 (2018-2029)
  • 世界のうっ血性心不全治療装置 収益：タイプ別
    • 世界のうっ血性心不全治療装置の収益実績：タイプ別 (2018-2023)
    • 世界のうっ血性心不全治療装置の収益予測：タイプ別 (2024-2029)
    • 世界のうっ血性心不全治療装置の収益市場シェア：タイプ別 (2018-2029)
  • 世界のうっ血性心不全治療装置の価格：タイプ別
    • 世界のうっ血性心不全治療装置の価格：タイプ別 (2018-2023)
    • 世界のうっ血性心不全治療装置の価格予測：タイプ別 (2024-2029)

第5章 市場規模：用途別

  • 世界のうっ血性心不全治療装置の販売：用途別
    • 世界のうっ血性心不全治療装置の販売実績：用途別 (2018-2023)
    • 世界のうっ血性心不全治療装置の販売予測：用途別 (2024-2029)
    • 世界のうっ血性心不全治療装置の販売市場シェア：用途別 (2018-2029)
  • 世界のうっ血性心不全治療装置の収益：用途別
    • 世界のうっ血性心不全治療装置の収益実績：用途別 (2018-2023)
    • 世界のうっ血性心不全治療装置の収益予測：用途別 (2024-2029)
    • 世界のうっ血性心不全治療装置の収益市場シェア：用途別 (2018-2029)
  • 世界のうっ血性心不全治療装置の価格：用途別
    • 世界のうっ血性心不全治療装置の価格：用途別 (2018-2023)
    • 世界のうっ血性心不全治療装置の価格予測：用途別 (2024-2029)

第6章 US & カナダ

  • US & カナダ うっ血性心不全治療装置 市場規模：タイプ別
    • US & カナダ うっ血性心不全治療装置の販売：タイプ別 (2018-2029)
    • US & カナダ うっ血性心不全治療装置 収益：タイプ別 (2018-2029)
  • US & カナダ うっ血性心不全治療装置 市場規模：用途別
    • US & カナダ うっ血性心不全治療装置の販売：用途別 (2018-2029)
    • US & カナダ うっ血性心不全治療装置の収益：用途別 (2018-2029)
  • US & カナダ うっ血性心不全治療装置 市場規模：国別
    • US & カナダ うっ血性心不全治療装置の収益：国別: 2018 VS 2022 VS 2029
    • US & カナダ うっ血性心不全治療装置の販売：国別 (2018-2029)
    • US & カナダ うっ血性心不全治療装置の収益：国別 (2018-2029)
    • US
    • カナダ

第7章 欧州

  • 欧州のうっ血性心不全治療装置 市場規模：タイプ別
    • 欧州のうっ血性心不全治療装置の販売：タイプ別 (2018-2029)
    • 欧州のうっ血性心不全治療装置 収益：タイプ別 (2018-2029)
  • 欧州のうっ血性心不全治療装置 市場規模：用途別
    • 欧州のうっ血性心不全治療装置の販売：用途別 (2018-2029)
    • 欧州のうっ血性心不全治療装置の収益：用途別 (2018-2029)
  • 欧州のうっ血性心不全治療装置 市場規模：国別
    • 欧州のうっ血性心不全治療装置の収益：国別: 2018 VS 2022 VS 2029
    • 欧州のうっ血性心不全治療装置の販売：国別 (2018-2029)
    • 欧州のうっ血性心不全治療装置の収益：国別 (2018-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 中国

  • 中国のうっ血性心不全治療装置 市場規模
    • 中国のうっ血性心不全治療装置 売上 (2018-2029)
    • 中国のうっ血性心不全治療装置 収益 (2018-2029)
  • 中国のうっ血性心不全治療装置 市場規模：用途別
    • 中国のうっ血性心不全治療装置の販売：用途別 (2018-2029)
    • 中国のうっ血性心不全治療装置の収益：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 うっ血性心不全治療装置 市場規模：タイプ別
    • アジア地域 うっ血性心不全治療装置の販売：タイプ別 (2018-2029)
    • アジア地域 うっ血性心不全治療装置 収益：タイプ別 (2018-2029)
  • アジア地域 うっ血性心不全治療装置 市場規模：用途別
    • アジア地域 うっ血性心不全治療装置の販売：用途別 (2018-2029)
    • アジア地域 うっ血性心不全治療装置の収益：用途別 (2018-2029)
  • アジア地域 うっ血性心不全治療装置の販売：地域別
    • アジア地域 うっ血性心不全治療装置の収益：地域別: 2018 VS 2022 VS 2029
    • アジア地域 うっ血性心不全治療装置の収益：地域別 (2018-2029)
    • アジア地域 うっ血性心不全治療装置の販売：地域別 (2018-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第10章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカのうっ血性心不全治療装置 市場規模：タイプ別
    • 中東, アフリカ ・ラテンアメリカのうっ血性心不全治療装置の販売：タイプ別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカのうっ血性心不全治療装置 収益：タイプ別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカのうっ血性心不全治療装置 市場規模：用途別
    • 中東, アフリカ ・ラテンアメリカのうっ血性心不全治療装置の販売：用途別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカのうっ血性心不全治療装置の収益：用途別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカのうっ血性心不全治療装置の販売：国別
    • 中東, アフリカ ・ラテンアメリカのうっ血性心不全治療装置の収益：国別: 2018 VS 2022 VS 2029
    • 中東, アフリカ ・ラテンアメリカのうっ血性心不全治療装置の収益：国別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカのうっ血性心不全治療装置の販売：国別 (2018-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第11章 企業プロファイル

  • Abiomed
  • Berlin Heart GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • HeartWare International
  • Jarvik Heart
  • LivaNova PLC
  • Medtronic
  • ReliantHeart
  • Abbott

第12章 業界チェーンと販売チャネルの分析

  • うっ血性心不全治療装置 業界チェーン分析
  • うっ血性心不全治療装置 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • うっ血性心不全治療装置 生産形態とプロセス
  • うっ血性心不全治療装置 販売およびマーケティング
    • うっ血性心不全治療装置 販売チャネル
    • うっ血性心不全治療装置 卸業者
  • うっ血性心不全治療装置 顧客

第13章 市場動向

  • うっ血性心不全治療装置 業界動向
  • うっ血性心不全治療装置 市場の促進要因
  • うっ血性心不全治療装置 市場の課題
  • うっ血性心不全治療装置 市場の抑制要因

第14章 主な調査結果 世界のうっ血性心不全治療装置の主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of Cardiac Resynchronization Therapy (CRT)
  • Table 3. Major Manufacturers of Implantable Cardioverter Defibrillators (ICDs)
  • Table 4. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 5. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 6. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2018-2023) & (US$ Million)
  • Table 7. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2024-2029) & (US$ Million)
  • Table 8. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2018-2023)
  • Table 9. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2024-2029)
  • Table 10. Global Congestive Heart Failure (CHF) Treatment Devices Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 11. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2018-2023) & (K Units)
  • Table 12. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2024-2029) & (K Units)
  • Table 13. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2018-2023)
  • Table 14. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2024-2029)
  • Table 15. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturers (2018-2023) & (K Units)
  • Table 16. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Manufacturers (2018-2023)
  • Table 17. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 18. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Manufacturers (2018-2023)
  • Table 19. Global Key Players of Congestive Heart Failure (CHF) Treatment Devices, Industry Ranking, 2021 VS 2022 VS 2023
  • Table 20. Congestive Heart Failure (CHF) Treatment Devices Price by Manufacturers 2018-2023 (USD/Unit)
  • Table 21. Global Congestive Heart Failure (CHF) Treatment Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 22. Global Congestive Heart Failure (CHF) Treatment Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Congestive Heart Failure (CHF) Treatment Devices as of 2022)
  • Table 23. Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Manufacturing Base Distribution and Headquarters
  • Table 24. Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Product Offered and Application
  • Table 25. Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Date of Enter into This Industry
  • Table 26. Mergers & Acquisitions, Expansion Plans
  • Table 27. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (K Units)
  • Table 28. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2024-2029) & (K Units)
  • Table 29. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2018-2023)
  • Table 30. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2024-2029)
  • Table 31. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2018-2023) & (US$ Million)
  • Table 32. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2024-2029) & (US$ Million)
  • Table 33. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2018-2023)
  • Table 34. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2024-2029)
  • Table 35. Congestive Heart Failure (CHF) Treatment Devices Price by Type (2018-2023) & (USD/Unit)
  • Table 36. Global Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Type (2024-2029) & (USD/Unit)
  • Table 37. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (K Units)
  • Table 38. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2024-2029) & (K Units)
  • Table 39. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2018-2023)
  • Table 40. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2024-2029)
  • Table 41. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2018-2023) & (US$ Million)
  • Table 42. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2024-2029) & (US$ Million)
  • Table 43. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Application (2018-2023)
  • Table 44. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Application (2024-2029)
  • Table 45. Congestive Heart Failure (CHF) Treatment Devices Price by Application (2018-2023) & (USD/Unit)
  • Table 46. Global Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Application (2024-2029) & (USD/Unit)
  • Table 47. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (K Units)
  • Table 48. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2024-2029) & (K Units)
  • Table 49. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2018-2023) & (US$ Million)
  • Table 50. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2024-2029) & (US$ Million)
  • Table 51. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (K Units)
  • Table 52. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2024-2029) & (K Units)
  • Table 53. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2018-2023) & (US$ Million)
  • Table 54. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2024-2029) & (US$ Million)
  • Table 55. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 56. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2018-2023) & (US$ Million)
  • Table 57. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2024-2029) & (US$ Million)
  • Table 58. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023) & (K Units)
  • Table 59. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2024-2029) & (K Units)
  • Table 60. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (K Units)
  • Table 61. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2024-2029) & (K Units)
  • Table 62. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2018-2023) & (US$ Million)
  • Table 63. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2024-2029) & (US$ Million)
  • Table 64. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (K Units)
  • Table 65. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2024-2029) & (K Units)
  • Table 66. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2018-2023) & (US$ Million)
  • Table 67. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2024-2029) & (US$ Million)
  • Table 68. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 69. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2018-2023) & (US$ Million)
  • Table 70. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2024-2029) & (US$ Million)
  • Table 71. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023) & (K Units)
  • Table 72. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2024-2029) & (K Units)
  • Table 73. China Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (K Units)
  • Table 74. China Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2024-2029) & (K Units)
  • Table 75. China Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2018-2023) & (US$ Million)
  • Table 76. China Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2024-2029) & (US$ Million)
  • Table 77. China Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (K Units)
  • Table 78. China Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2024-2029) & (K Units)
  • Table 79. China Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2018-2023) & (US$ Million)
  • Table 80. China Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2024-2029) & (US$ Million)
  • Table 81. Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (K Units)
  • Table 82. Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2024-2029) & (K Units)
  • Table 83. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2018-2023) & (US$ Million)
  • Table 84. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2024-2029) & (US$ Million)
  • Table 85. Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (K Units)
  • Table 86. Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2024-2029) & (K Units)
  • Table 87. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2018-2023) & (US$ Million)
  • Table 88. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2024-2029) & (US$ Million)
  • Table 89. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 90. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2018-2023) & (US$ Million)
  • Table 91. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2024-2029) & (US$ Million)
  • Table 92. Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2018-2023) & (K Units)
  • Table 93. Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2024-2029) & (K Units)
  • Table 94. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (K Units)
  • Table 95. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2024-2029) & (K Units)
  • Table 96. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2018-2023) & (US$ Million)
  • Table 97. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2024-2029) & (US$ Million)
  • Table 98. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (K Units)
  • Table 99. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2024-2029) & (K Units)
  • Table 100. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2018-2023) & (US$ Million)
  • Table 101. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2024-2029) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 103. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2018-2023) & (US$ Million)
  • Table 104. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2024-2029) & (US$ Million)
  • Table 105. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023) & (K Units)
  • Table 106. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2024-2029) & (K Units)
  • Table 107. Abiomed Company Information
  • Table 108. Abiomed Description and Major Businesses
  • Table 109. Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 110. Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 111. Abiomed Recent Developments
  • Table 112. Berlin Heart GmbH Company Information
  • Table 113. Berlin Heart GmbH Description and Major Businesses
  • Table 114. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 115. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 116. Berlin Heart GmbH Recent Developments
  • Table 117. Biotronik SE & Co. KG Company Information
  • Table 118. Biotronik SE & Co. KG Description and Major Businesses
  • Table 119. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 120. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 121. Biotronik SE & Co. KG Recent Developments
  • Table 122. Boston Scientific Corporation Company Information
  • Table 123. Boston Scientific Corporation Description and Major Businesses
  • Table 124. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 125. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 126. Boston Scientific Corporation Recent Developments
  • Table 127. HeartWare International Company Information
  • Table 128. HeartWare International Description and Major Businesses
  • Table 129. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 130. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 131. HeartWare International Recent Developments
  • Table 132. Jarvik Heart Company Information
  • Table 133. Jarvik Heart Description and Major Businesses
  • Table 134. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 135. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 136. Jarvik Heart Recent Developments
  • Table 137. LivaNova PLC Company Information
  • Table 138. LivaNova PLC Description and Major Businesses
  • Table 139. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 140. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 141. LivaNova PLC Recent Developments
  • Table 142. Medtronic Company Information
  • Table 143. Medtronic Description and Major Businesses
  • Table 144. Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 145. Medtronic Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 146. Medtronic Recent Developments
  • Table 147. ReliantHeart Company Information
  • Table 148. ReliantHeart Description and Major Businesses
  • Table 149. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 150. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 151. ReliantHeart Recent Developments
  • Table 152. Abbott Company Information
  • Table 153. Abbott Description and Major Businesses
  • Table 154. Abbott Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 155. Abbott Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 156. Abbott Recent Developments
  • Table 157. Key Raw Materials Lists
  • Table 158. Raw Materials Key Suppliers Lists
  • Table 159. Congestive Heart Failure (CHF) Treatment Devices Distributors List
  • Table 160. Congestive Heart Failure (CHF) Treatment Devices Customers List
  • Table 161. Congestive Heart Failure (CHF) Treatment Devices Market Trends
  • Table 162. Congestive Heart Failure (CHF) Treatment Devices Market Drivers
  • Table 163. Congestive Heart Failure (CHF) Treatment Devices Market Challenges
  • Table 164. Congestive Heart Failure (CHF) Treatment Devices Market Restraints
  • Table 165. Research Programs/Design for This Report
  • Table 166. Key Data Information from Secondary Sources
  • Table 167. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Congestive Heart Failure (CHF) Treatment Devices Product Picture
  • Figure 2. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Type in 2022 & 2029
  • Figure 4. Cardiac Resynchronization Therapy (CRT) Product Picture
  • Figure 5. Implantable Cardioverter Defibrillators (ICDs) Product Picture
  • Figure 6. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Application in 2022 & 2029
  • Figure 8. Left Ventricular Assist Device (LVAD)
  • Figure 9. Right Ventricular Assist Device (RVAD)
  • Figure 10. Biventricular Assist Device (BIVAD)
  • Figure 11. Congestive Heart Failure (CHF) Treatment Devices Report Years Considered
  • Figure 12. Global Congestive Heart Failure (CHF) Treatment Devices Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 13. Global Congestive Heart Failure (CHF) Treatment Devices Revenue 2018-2029 (US$ Million)
  • Figure 14. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 15. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2018-2029)
  • Figure 16. Global Congestive Heart Failure (CHF) Treatment Devices Sales 2018-2029 ((K Units)
  • Figure 17. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2018-2029)
  • Figure 18. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales YoY (2018-2029) & (K Units)
  • Figure 19. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue YoY (2018-2029) & (US$ Million)
  • Figure 20. Europe Congestive Heart Failure (CHF) Treatment Devices Sales YoY (2018-2029) & (K Units)
  • Figure 21. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue YoY (2018-2029) & (US$ Million)
  • Figure 22. China Congestive Heart Failure (CHF) Treatment Devices Sales YoY (2018-2029) & (K Units)
  • Figure 23. China Congestive Heart Failure (CHF) Treatment Devices Revenue YoY (2018-2029) & (US$ Million)
  • Figure 24. Asia (excluding China) Congestive Heart Failure (CHF) Treatment Devices Sales YoY (2018-2029) & (K Units)
  • Figure 25. Asia (excluding China) Congestive Heart Failure (CHF) Treatment Devices Revenue YoY (2018-2029) & (US$ Million)
  • Figure 26. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales YoY (2018-2029) & (K Units)
  • Figure 27. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue YoY (2018-2029) & (US$ Million)
  • Figure 28. The Congestive Heart Failure (CHF) Treatment Devices Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
  • Figure 29. The Top 5 and 10 Largest Manufacturers of Congestive Heart Failure (CHF) Treatment Devices in the World: Market Share by Congestive Heart Failure (CHF) Treatment Devices Revenue in 2022
  • Figure 30. Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 31. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2018-2029)
  • Figure 32. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2018-2029)
  • Figure 33. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2018-2029)
  • Figure 34. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2018-2029)
  • Figure 35. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2018-2029)
  • Figure 36. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2018-2029)
  • Figure 37. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2018-2029)
  • Figure 38. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2018-2029)
  • Figure 39. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Country (2018-2029)
  • Figure 40. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales Share by Country (2018-2029)
  • Figure 41. U.S. Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029) & (US$ Million)
  • Figure 42. Canada Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029) & (US$ Million)
  • Figure 43. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2018-2029)
  • Figure 44. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2018-2029)
  • Figure 45. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2018-2029)
  • Figure 46. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2018-2029)
  • Figure 47. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Country (2018-2029)
  • Figure 48. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Share by Country (2018-2029)
  • Figure 49. Germany Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029) & (US$ Million)
  • Figure 50. France Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029) & (US$ Million)
  • Figure 51. U.K. Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029) & (US$ Million)
  • Figure 52. Italy Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029) & (US$ Million)
  • Figure 53. Russia Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029) & (US$ Million)
  • Figure 54. China Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2018-2029)
  • Figure 55. China Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2018-2029)
  • Figure 56. China Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2018-2029)
  • Figure 57. China Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2018-2029)
  • Figure 58. Asia Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2018-2029)
  • Figure 59. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2018-2029)
  • Figure 60. Asia Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2018-2029)
  • Figure 61. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2018-2029)
  • Figure 62. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Region (2018-2029)
  • Figure 63. Asia Congestive Heart Failure (CHF) Treatment Devices Sales Share by Region (2018-2029)
  • Figure 64. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029) & (US$ Million)
  • Figure 65. South Korea Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029) & (US$ Million)
  • Figure 66. China Taiwan Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029) & (US$ Million)
  • Figure 67. Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029) & (US$ Million)
  • Figure 68. India Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029) & (US$ Million)
  • Figure 69. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2018-2029)
  • Figure 70. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2018-2029)
  • Figure 71. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2018-2029)
  • Figure 72. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2018-2029)
  • Figure 73. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Country (2018-2029)
  • Figure 74. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Share by Country (2018-2029)
  • Figure 75. Brazil Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029) & (US$ Million)
  • Figure 76. Mexico Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029) & (US$ Million)
  • Figure 77. Turkey Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029) & (US$ Million)
  • Figure 78. Israel Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029) & (US$ Million)
  • Figure 79. GCC Countries Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029) & (US$ Million)
  • Figure 80. Congestive Heart Failure (CHF) Treatment Devices Value Chain
  • Figure 81. Congestive Heart Failure (CHF) Treatment Devices Production Process
  • Figure 82. Channels of Distribution
  • Figure 83. Distributors Profiles
  • Figure 84. Bottom-up and Top-down Approaches for This Report
  • Figure 85. Data Triangulation
  • Figure 86. Key Executives Interviewed
目次

This research report focuses on the Congestive Heart Failure (CHF) Treatment Devices Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Congestive Heart Failure (CHF) Treatment Devices Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Cardiac Resynchronization Therapy (CRT)
    • 1.2.3 Implantable Cardioverter Defibrillators (ICDs)
  • 1.3 Market by Application
    • 1.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Left Ventricular Assist Device (LVAD)
    • 1.3.3 Right Ventricular Assist Device (RVAD)
    • 1.3.4 Biventricular Assist Device (BIVAD)
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Estimates and Forecasts 2018-2029
  • 2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region
    • 2.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2018-2023)
    • 2.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2024-2029)
    • 2.2.4 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2018-2029)
  • 2.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Estimates and Forecasts 2018-2029
  • 2.4 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region
    • 2.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2018-2023)
    • 2.4.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2024-2029)
    • 2.4.4 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2018-2029)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturers
    • 3.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturers (2018-2023)
    • 3.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Congestive Heart Failure (CHF) Treatment Devices in 2022
  • 3.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Manufacturers
    • 3.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top 10 and Top 5 Companies by Congestive Heart Failure (CHF) Treatment Devices Revenue in 2022
  • 3.3 Global Key Players of Congestive Heart Failure (CHF) Treatment Devices, Industry Ranking, 2021 VS 2022 VS 2023
  • 3.4 Global Congestive Heart Failure (CHF) Treatment Devices Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Product Offered and Application
  • 3.8 Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type
    • 4.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Historical Sales by Type (2018-2023)
    • 4.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2018-2029)
  • 4.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type
    • 4.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Historical Revenue by Type (2018-2023)
    • 4.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2018-2029)
  • 4.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Type
    • 4.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (2018-2023)
    • 4.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Type (2024-2029)

5 Market Size by Application

  • 5.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application
    • 5.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Historical Sales by Application (2018-2023)
    • 5.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2018-2029)
  • 5.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application
    • 5.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Historical Revenue by Application (2018-2023)
    • 5.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2018-2029)
  • 5.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Application
    • 5.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (2018-2023)
    • 5.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Application (2024-2029)

6 US & Canada

  • 6.1 US & Canada Congestive Heart Failure (CHF) Treatment Devices Market Size by Type
    • 6.1.1 US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2029)
    • 6.1.2 US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2018-2029)
  • 6.2 US & Canada Congestive Heart Failure (CHF) Treatment Devices Market Size by Application
    • 6.2.1 US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2029)
    • 6.2.2 US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2018-2029)
  • 6.3 US & Canada Congestive Heart Failure (CHF) Treatment Devices Market Size by Country
    • 6.3.1 US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2029)
    • 6.3.3 US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Congestive Heart Failure (CHF) Treatment Devices Market Size by Type
    • 7.1.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2029)
    • 7.1.2 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2018-2029)
  • 7.2 Europe Congestive Heart Failure (CHF) Treatment Devices Market Size by Application
    • 7.2.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2029)
    • 7.2.2 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2018-2029)
  • 7.3 Europe Congestive Heart Failure (CHF) Treatment Devices Market Size by Country
    • 7.3.1 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2029)
    • 7.3.3 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China Congestive Heart Failure (CHF) Treatment Devices Market Size
    • 8.1.1 China Congestive Heart Failure (CHF) Treatment Devices Sales (2018-2029)
    • 8.1.2 China Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2029)
  • 8.2 China Congestive Heart Failure (CHF) Treatment Devices Market Size by Application
    • 8.2.1 China Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2029)
    • 8.2.2 China Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Congestive Heart Failure (CHF) Treatment Devices Market Size by Type
    • 9.1.1 Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2029)
    • 9.1.2 Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2018-2029)
  • 9.2 Asia Congestive Heart Failure (CHF) Treatment Devices Market Size by Application
    • 9.2.1 Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2029)
    • 9.2.2 Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2018-2029)
  • 9.3 Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Region
    • 9.3.1 Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2018-2029)
    • 9.3.3 Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2018-2029)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2029)
    • 10.1.2 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2018-2029)
  • 10.2 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2029)
    • 10.2.2 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2018-2029)
  • 10.3 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country
    • 10.3.1 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2018-2029)
    • 10.3.3 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2029)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Abiomed
    • 11.1.1 Abiomed Company Information
    • 11.1.2 Abiomed Overview
    • 11.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Abiomed Recent Developments
  • 11.2 Berlin Heart GmbH
    • 11.2.1 Berlin Heart GmbH Company Information
    • 11.2.2 Berlin Heart GmbH Overview
    • 11.2.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Berlin Heart GmbH Recent Developments
  • 11.3 Biotronik SE & Co. KG
    • 11.3.1 Biotronik SE & Co. KG Company Information
    • 11.3.2 Biotronik SE & Co. KG Overview
    • 11.3.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Biotronik SE & Co. KG Recent Developments
  • 11.4 Boston Scientific Corporation
    • 11.4.1 Boston Scientific Corporation Company Information
    • 11.4.2 Boston Scientific Corporation Overview
    • 11.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Boston Scientific Corporation Recent Developments
  • 11.5 HeartWare International
    • 11.5.1 HeartWare International Company Information
    • 11.5.2 HeartWare International Overview
    • 11.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 HeartWare International Recent Developments
  • 11.6 Jarvik Heart
    • 11.6.1 Jarvik Heart Company Information
    • 11.6.2 Jarvik Heart Overview
    • 11.6.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.6.4 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Jarvik Heart Recent Developments
  • 11.7 LivaNova PLC
    • 11.7.1 LivaNova PLC Company Information
    • 11.7.2 LivaNova PLC Overview
    • 11.7.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 LivaNova PLC Recent Developments
  • 11.8 Medtronic
    • 11.8.1 Medtronic Company Information
    • 11.8.2 Medtronic Overview
    • 11.8.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 Medtronic Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Medtronic Recent Developments
  • 11.9 ReliantHeart
    • 11.9.1 ReliantHeart Company Information
    • 11.9.2 ReliantHeart Overview
    • 11.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.9.4 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 ReliantHeart Recent Developments
  • 11.10 Abbott
    • 11.10.1 Abbott Company Information
    • 11.10.2 Abbott Overview
    • 11.10.3 Abbott Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.10.4 Abbott Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Abbott Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Congestive Heart Failure (CHF) Treatment Devices Industry Chain Analysis
  • 12.2 Congestive Heart Failure (CHF) Treatment Devices Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Congestive Heart Failure (CHF) Treatment Devices Production Mode & Process
  • 12.4 Congestive Heart Failure (CHF) Treatment Devices Sales and Marketing
    • 12.4.1 Congestive Heart Failure (CHF) Treatment Devices Sales Channels
    • 12.4.2 Congestive Heart Failure (CHF) Treatment Devices Distributors
  • 12.5 Congestive Heart Failure (CHF) Treatment Devices Customers

13 Market Dynamics

  • 13.1 Congestive Heart Failure (CHF) Treatment Devices Industry Trends
  • 13.2 Congestive Heart Failure (CHF) Treatment Devices Market Drivers
  • 13.3 Congestive Heart Failure (CHF) Treatment Devices Market Challenges
  • 13.4 Congestive Heart Failure (CHF) Treatment Devices Market Restraints

14 Key Findings in The Global Congestive Heart Failure (CHF) Treatment Devices Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer